UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028558
Receipt number R000032684
Scientific Title Availability of endoscopic ultrasonography for the diagnosis of choledocholithiasis undetected by other modalities: multicenter non-randomized, non-blind exploratory clinical trial
Date of disclosure of the study information 2017/08/07
Last modified on 2021/02/08 20:57:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Availability of endoscopic ultrasonography for the diagnosis of choledocholithiasis undetected by other modalities: multicenter non-randomized, non-blind exploratory clinical trial

Acronym

EUS biliary stone study

Scientific Title

Availability of endoscopic ultrasonography for the diagnosis of choledocholithiasis undetected by other modalities: multicenter non-randomized, non-blind exploratory clinical trial

Scientific Title:Acronym

EUS biliary stone study

Region

Japan


Condition

Condition

choledocholithiasis

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the efficacy of endoscopic ultrasonography on the diagnosis of choledocholithiasis in patients who are suspected of having choledocholithiasis, but cannot be diagnosed by US, CT and MRCP

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Diagnostic accuracy of EUS for choledocholithiasis

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Age of 20 years or older
(2) Suspected of having choledocholithiasis with epigastralgia/ right hypochondralgia due to unknown origin or serum elevated levels of T-bilirubin, AST, ALT, gamma-GT and ALP
(3) Highly suspeted of having choledocholithiasis based on ASGE guideline
(4) Performance Status (PS) Grade 0-3
(5) Being able to providing informed consent for participation

Key exclusion criteria

(1) Having a biliary stone detected by any of US, CT or MRCP
(2) Severe cholangitis (Grade III) based on Tokyo guideline 2013
(3) Bile duct stricture detected by any of US, CT, MRCP
(4) Having the past history of endoscopic treatment of choledocholithiasis
(5) Intubated with a biliary stent
(6) Ampullary tumor
(7) Having tumor invation at the major papilla
(8) With Billroth II or Roux-en-Y reconstruction after gastrectomy
(9) Choledocho-duodenal fistula
(10) Consciousness disturbance with Japan Coma Scale (JCS) I-2 or severe
(11)(12) Severe cardiopulmonary disease
(13) Pregnancy or during breast-feeding
(14) Judged inappropriate by a research director

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Masaki
Middle name
Last name Kuwatani

Organization

Hokkaido University Hospital

Division name

Division of Endoscopy

Zip code

060-8648

Address

North 14, West 5, Kita-ku, Sapporo

TEL

011-716-1161

Email

mkuwatan@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Masaki
Middle name
Last name Kuwatani

Organization

Hokkaido University Faculty of Medicine and Graduate School of Medicine

Division name

Department of Gastroenterology and Hepatology

Zip code

060-8648

Address

North 15, West 7, Kita-ku, Sapporo

TEL

011-716-1161

Homepage URL


Email

mkuwatan@med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University Hospital, Division of Clinical Research Administration

Address

North 14, West 5, Kita-ku, Sapporo

Tel

011-706-7636

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 08 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 07 Month 12 Day

Date of IRB

2017 Year 07 Month 11 Day

Anticipated trial start date

2017 Year 07 Month 28 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Data as follows are recorded in daily clinical practice and used in the present study. (1) Patient characteristics: height, body weight, illness history, treatment history, age, gender, diagnosis (2) Hematology (3) Serum biochemistry: Total protein, albumin, amylase, lipase, AST, ALT, LDH, gamma-GT, ALP, T-bilirubin, D-bilirubin, fast glucose, creatinine, BUN, Na, K, Cl, Ca, CRP (4) coagulation system: PT-INR (5) ECG, chest radiograph, abdomen radiograph, US, CT, MRCP


Management information

Registered date

2017 Year 08 Month 07 Day

Last modified on

2021 Year 02 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032684


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name